These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9142574)

  • 1. Growth hormone and insulin-like growth factors in critical illness.
    Gibson FA; Hinds CJ
    Intensive Care Med; 1997 Apr; 23(4):369-78. PubMed ID: 9142574
    [No Abstract]   [Full Text] [Related]  

  • 2. Anabolic strategies in critical illness.
    Hadley JS; Hinds CJ
    Curr Opin Pharmacol; 2002 Dec; 2(6):700-7. PubMed ID: 12482734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological effects and potential applications of GH and IGF-I.
    Fryburg DA; Barrett EJ
    Diabetes Nutr Metab; 1999 Oct; 12(5):329-36. PubMed ID: 10741347
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of nitric oxide in the haemodynamic effects of growth hormone.
    Böger RH
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():163-5. PubMed ID: 10990155
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin-like growth factor I for growth hormone therapy.
    Liao W; Rudling M; Angelin B
    Lancet; 2000 Jan; 355(9198):148. PubMed ID: 10675196
    [No Abstract]   [Full Text] [Related]  

  • 6. The GH/IGF-1 system in critical illness.
    Elijah IE; Branski LK; Finnerty CC; Herndon DN
    Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):759-67. PubMed ID: 21925076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors in critical illness: regulation and therapeutic aspects.
    Frost RA; Lang CH
    Curr Opin Clin Nutr Metab Care; 1998 Mar; 1(2):195-204. PubMed ID: 10565348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient.
    Carroll PV
    Growth Horm IGF Res; 1999 Dec; 9(6):400-13. PubMed ID: 10629160
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible therapeutic effects of growth hormone on wound healing in the diabetic patient.
    Massey KA; Blakeslee C; Pitkow HS
    J Am Podiatr Med Assoc; 1998 Jan; 88(1):25-9. PubMed ID: 9458630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and IGF-I therapy in the hypercatabolic patient.
    Wolf SE; Barrow RE; Herndon DN
    Baillieres Clin Endocrinol Metab; 1996 Jul; 10(3):447-63. PubMed ID: 8853450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with GH and IGF-1 in critical illness.
    Teng Chung T; Hinds CJ
    Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH-deficient adults.
    Bianda TL; Glatz Y; Boeni-Schnetzler M; Froesch ER; Schmid C
    Diabetologia; 1997 Mar; 40(3):363-4. PubMed ID: 9084980
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased mortality associated with growth hormone treatment in critically ill adults.
    Van den Berghe G
    N Engl J Med; 2000 Jan; 342(2):135; author reply 135-6. PubMed ID: 10636755
    [No Abstract]   [Full Text] [Related]  

  • 15. Human pituitary growth hormone and cancer risk.
    Kalra PR; Genth-Zotz S; Coats AJ; Anker SD
    Lancet; 2002 Nov; 360(9347):1791-2. PubMed ID: 12480468
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB; Wollmann HA; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of growth hormone and insulin-like growth factors on human osteoblasts.
    Ohlsson C; Vidal O
    Eur J Clin Invest; 1998 Mar; 28(3):184-6. PubMed ID: 9568462
    [No Abstract]   [Full Text] [Related]  

  • 18. Protein anabolic action of insulin, growth hormone and insulin-like growth factor I.
    Russell-Jones DL; Umpleby M
    Eur J Endocrinol; 1996 Dec; 135(6):631-42. PubMed ID: 9025701
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased mortality associated with growth hormone treatment in critically ill adults.
    Osterziel KJ; Dietz R; Ranke MB
    N Engl J Med; 2000 Jan; 342(2):134-5; author reply 135-6. PubMed ID: 10636754
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I.
    Theiss AL; Fruchtman S; Lund PK
    Inflamm Bowel Dis; 2004 Nov; 10(6):871-80. PubMed ID: 15626905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.